New course!
This series includes three workshops on Complementary Medicines in Australia, including: 1) Introduction To Complementary Medicines in Australia for Regulatory, Quality and Product Development Professionals on 21-Apr-2026, 2) Complementary Medicines Listings on 28-Apr-2026 and 3) Complementary Medicines – Key Regulatory and Quality Requirements for Successful Product Launches on 05-May-2026.
Tina Bird: RegPartners | Director & Principal Consultant
With over 20 years of experience in the pharmaceutical industry, Tina has a proven track record in guiding businesses through the complexities of complementary and over-the-counter medicines. She has worked with leading companies such as Bristol- Myers Squibb, Catalent Pharma Solutions, and Blackmores Group, delivering strategic solutions to bring high-quality products to markets across Australia, New Zealand, Asia, and the USA. Tina’s expertise spans regulatory strategy, new product development, TGA compliance, GMP quality systems, and the development of customized training programs. Known for her practical and results-driven approach, she ensures businesses overcome regulatory and quality challenges efficiently and with confidence.
As the director of RegPartners, Tina is passionate about empowering health and wellness companies to achieve compliance and drive growth. Through her tailored support in regulatory affairs, quality management, advertising compliance, and training, she is committed to fostering collaboration, promoting industry best practices, and making a meaningful impact in the industry.
21-Apr-2026 10:30 AM AEST to 12:00 PM AEST
This session introduces the regulatory framework for complementary medicines in Australia, focusing on their unique classification, compliance requirements, and the responsibilities of sponsors. It provides an essential foundation for understanding the Therapeutic Goods Administration's (TGA) role and equips participants with practical insights into listing and managing complementary medicines.
At the end of this session, attendees will:
1. Understand what complementary medicines are and how they are regulated in Australia.
2. Learn how complementary medicines differ from food, cosmetics and sports supplements.
3. Gain insight into TGA fees, approved ingredients, and permissible claims.
4. Learn key requirements for labelling, advertising, and export compliance.
This introductory training is designed for professionals new to the complementary medicines industry or those seeking to enhance their knowledge of Australian regulations. It is particularly relevant to:
• Individuals working in regulatory affairs, quality assurance, or product development for complementary medicines.
• Small to medium-sized business owners entering the Australian complementary medicines market.
• Health and wellness entrepreneurs seeking to navigate TGA requirements.
• Graduates or professionals transitioning into regulated industries who want foundational knowledge of complementary medicines regulations.
Whether you are exploring the industry for the first time or looking to refine your understanding of the regulatory framework, this session will provide valuable insights to
help you navigate the complexities of the Australian market with confidence.
28-Apr-2026 10:30 AM AEST to 12:00 PM AEST
Listing complementary medicines on the Australian Register of Therapeutic Goods (ARTG) is a crucial step for ensuring compliance with TGA regulations. This process involves navigating specific requirements, from gathering the necessary information to understanding the certifications required for submission. As a sponsor, maintaining compliance extends beyond listing, encompassing ongoing responsibilities such as product monitoring and reporting obligations. This training session will demystify the ARTG listing process, guiding participants through the key steps, documentation requirements, and critical considerations for successful submissions. Attendees will also learn about the responsibilities of sponsors post-listing and the certifications that underpin compliance in this regulated environment.
At the end of this session, attendees will:
1. Understand the steps involved in listing complementary medicines on the ARTG.
2. Identify the key information and documentation required for submissions.
3. Learn the specific certifications necessary for compliance.
4. Gain insight into the ongoing responsibilities of sponsors, including recordkeeping and reporting requirements.
5. Be equipped to confidently manage ARTG listing processes and maintain compliance post-listing.
This session is designed for:
• Regulatory affairs professionals involved in listing complementary medicines on the ARTG.
• Quality assurance personnel responsible for maintaining compliance with TGA requirements.
• Small to medium-sized business owners navigating ARTG listings.
• Entrepreneurs in the health and wellness industry looking to market compliant complementary medicines in Australia.
• Graduates or professionals transitioning into regulated industries who want to build foundational knowledge of ARTG listings and sponsor responsibilities.
Whether you are new to the field or seeking to enhance your understanding of ARTG processes, this training will provide actionable insights and practical knowledge.
05-May-2026 10:30 AM AEST to 12:00 PM AEST
Launching complementary medicines in Australia requires a structured approach that integrates regulatory and quality requirements at every stage of the product development process. From feasibility to post-launch activities, each step is critical to ensure compliance with TGA standards and international guidelines, safeguarding product quality and consumer trust. This session will provide participants with an overview of the regulatory and quality requirements associated with product development, validation, execution, and postlaunch processes. Through practical insights, attendees will be equipped to streamline workflows and achieve market readiness effectively.
At the end of this session, attendees will:
1. Understand the regulatory and quality considerations at each stage of product development.
2. Gain insights into claims substantiation and product testing requirements.
3. Understand requirements for selecting manufacturers and GMP clearance.
4. Learn about post-launch activities, including change management, ongoing stability and pharmacovigilance.
This session is tailored for:
• Regulatory affairs professionals.
• Quality assurance and control personnel.
• Product development teams in the complementary medicines industry.
• Sponsors and business owners navigating regulatory requirements.
• Graduates or industry newcomers seeking foundational knowledge of regulatory processes.
Whether you’re new to the industry or seeking to refine your approach, this session offers actionable insights to help you succeed in the competitive complementary medicines market.
ARCS member - $486 +GST = $534.60 incl. GST for the series.
Non-member - $675 +GST = $742.50 incl. GST for the series.
.png){kind=logo}
.png)
%20(2).jpg)
